Unnamed: 0,title,date,stock,sentiment
1073370.0,"The Daily Biotech Pulse: Sorrento Submits EUA Application For Rapid Coronavirus Test, Decision Day For Viela, Lantern Pharma IPO",2020-06-11 08:12:00-04:00,RDY,neutral
1073371.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,RDY,positive
1073372.0,Midatech Pharma PLC Announces Research Collaboration with Dr Reddy's,2020-06-08 05:16:00-04:00,RDY,neutral
1073373.0,Generic Threat To Amarin's Vascepa Overrides Positive Sentiment On Coronavirus Announcement,2020-05-22 13:15:00-04:00,RDY,positive
1073374.0,70 Biggest Movers From Yesterday,2020-05-21 05:22:00-04:00,RDY,neutral
1073375.0,52 Stocks Moving In Wednesday's Mid-Day Session,2020-05-20 13:17:00-04:00,RDY,neutral
1073376.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-05-20 07:16:00-04:00,RDY,neutral
1073377.0,"Dr Reddy's Laboratories Q4 EPS $0.610 Beats $0.490 Estimate, Sales $588.000M Up From $581.000M YoY",2020-05-20 06:45:00-04:00,RDY,neutral
1073378.0,"Earnings Scheduled For May 20, 2020",2020-05-20 05:10:00-04:00,RDY,neutral
1073379.0,"Dr. Reddy's Launches Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market",2020-05-06 05:32:00-04:00,RDY,neutral
1073380.0,FDA Grants Approval For Elyxyb Oral Solution Indicated For Acute Treatment Of Migraine With Or Without Aura In Adults To Dr. Reddy's Laboratories,2020-05-05 15:50:00-04:00,RDY,positive
1073381.0,"Dr. Reddy's Launches Fenofibrate Tablets USP, in the U.S. Market",2020-04-27 05:36:00-04:00,RDY,neutral
1073382.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,RDY,negative
1073383.0,Stocks That Hit 52-Week Highs On Wednesday,2020-04-22 10:20:00-04:00,RDY,neutral
1073384.0,Stocks That Hit 52-Week Highs On Friday,2020-04-17 10:19:00-04:00,RDY,neutral
1073385.0,"The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement",2020-04-17 07:35:00-04:00,RDY,positive
1073386.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-16 10:19:00-04:00,RDY,neutral
1073387.0,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",2020-04-15 08:03:00-04:00,RDY,neutral
1073388.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-14 10:31:00-04:00,RDY,neutral
1073389.0,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",2020-04-14 07:59:00-04:00,RDY,negative
1073390.0,"Dr. Reddy's Announces Launch of Amphetamine Sulfate Tablets USP, in the U.S. Market",2020-04-14 05:26:00-04:00,RDY,neutral
1073391.0,Dr. Reddy's Announces Launch of Authorized Generic Version of NitroDur Transdermal Infusion System in the U.S. Market,2020-04-14 05:25:00-04:00,RDY,neutral
1073392.0,Stocks That Hit 52-Week Highs On Monday,2020-04-13 10:25:00-04:00,RDY,neutral
1073393.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-09 10:25:00-04:00,RDY,neutral
1073394.0,"Dr. Reddy's Labs Reports Received Establishment Inspection Report From FDA For Audit Of API Manufacturing Plan 5 In Telangana, India",2020-04-09 06:28:00-04:00,RDY,neutral
1073395.0,Stocks That Hit 52-Week Highs On Wednesday,2020-04-08 10:44:00-04:00,RDY,neutral
1073396.0,"The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO",2020-04-08 07:53:00-04:00,RDY,neutral
1073397.0,"Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning Judgment",2020-03-31 10:53:00-04:00,RDY,negative
1073398.0,Amarin Shares Drop 67% As Court Invalidates Its Heart Drug Patent For Vascepa,2020-03-31 03:21:00-04:00,RDY,neutral
1073399.0,"Dr. Reddy's Labs Reports Voluntary Nationwide Recall Of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules, Cites Breakage, Shattering Upon Opening",2020-03-26 14:04:00-04:00,RDY,neutral
1073400.0,"Dr. Reddy's Launches Pyrimethamine Tablets USP, 25 mg, First-Wave Generic Version of Daraprim in the U.S. Market",2020-03-20 05:23:00-04:00,RDY,neutral
1073401.0,"Dr. Reddy's Laboratories Announces First-to-Market Launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe in the U.S. Market",2020-03-19 05:24:00-04:00,RDY,neutral
1073402.0,Dr. Reddy's Laboratories Announces Launch Of Ziprasidone Mesylate For Injection In US,2020-03-17 06:05:00-04:00,RDY,neutral
1073403.0,Dr. Reddy's Launches First Generic Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market,2020-02-27 05:20:00-05:00,RDY,neutral
1073404.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,RDY,negative
1073405.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-13 10:26:00-05:00,RDY,neutral
1073406.0,Dr. Reddy's Laboratories to Acquire Select Business Divisions of Wockhardt in India for Rs.1850 Crores,2020-02-12 05:01:00-05:00,RDY,neutral
1073407.0,"Dr. Reddy's Launches Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. Market",2020-02-07 05:27:00-05:00,RDY,neutral
1073408.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,RDY,neutral
1073409.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,RDY,positive
1073410.0,"Benzinga's Top Upgrades, Downgrades For January 28, 2020",2020-01-28 09:43:00-05:00,RDY,positive
1073411.0,"The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics",2020-01-28 07:12:00-05:00,RDY,positive
1073412.0,CLSA Downgrades Dr Reddy's Laboratories to Outperform,2020-01-28 06:47:00-05:00,RDY,neutral
1073413.0,20 Specialty & Generic Drug Manufacturer Stocks Moving In Monday's Session,2020-01-27 12:26:00-05:00,RDY,neutral
1073414.0,Stocks That Hit 52-Week Highs On Monday,2020-01-27 10:33:00-05:00,RDY,neutral
1073415.0,"Dr Reddy's Laboratories Earlier Reported Q3 EPS $0.63 Beats $0.51 Estimate, Sales $614M Up From $553M YoY",2020-01-27 09:09:00-05:00,RDY,neutral
1073416.0,"Earnings Scheduled For January 27, 2020",2020-01-27 04:12:00-05:00,RDY,neutral
1073417.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,RDY,positive
1073418.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-22 10:17:00-05:00,RDY,neutral
1073419.0,Citigroup Upgrades Dr Reddy's Laboratories to Buy,2020-01-09 11:42:00-05:00,RDY,neutral
1073420.0,Dr. Reddy's Shares Tick Higher On Volume As Hearing Citi Upgrades From Sell To Buy,2020-01-09 10:59:00-05:00,RDY,positive
1073421.0,"Dr. Reddy's Launches Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market",2019-12-30 05:06:00-05:00,RDY,neutral
1073422.0,"Dr. Reddy's Launches Deferasirox Film-Coated Tablets, in the U.S. Market",2019-12-06 05:16:00-05:00,RDY,neutral
1073423.0,"Dr. Reddy's Launches Deferasirox Tablets for Oral Suspension, in the U.S. Market",2019-12-06 05:15:00-05:00,RDY,neutral
1073424.0,Dr. Reddy's Laboratories Launches Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market,2019-12-04 05:04:00-05:00,RDY,neutral
1073425.0,Dr. Reddy's Laboratories Launches Doxercalciferol Injection in the U.S. Market,2019-11-22 05:34:00-05:00,RDY,neutral
1073426.0,Nuvo Pharma Gives an Update on its Patent Litigation with Dr Reddy's Laboratories,2019-11-11 07:46:00-05:00,RDY,negative
1073427.0,Bank of America Downgrades Dr Reddy's Laboratories to Neutral,2019-11-04 06:43:00-05:00,RDY,neutral
1073428.0,"Earnings Scheduled For November 1, 2019",2019-11-01 06:50:00-04:00,RDY,neutral
1073429.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,RDY,negative
1073430.0,"Dr. Reddy's Launches Over-the-Counter, Store-Brand Equivalent of Prevacid® 24HR Capsules (Lansoprazole Delayed-Release Capsules USP, 15 mg) in the U.S. Market",2019-09-16 03:49:00-04:00,RDY,neutral
1073431.0,24 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-09-13 08:44:00-04:00,RDY,neutral
1073432.0,"Four TB Cases Confirmed at El Paso, TX High School",2019-09-12 18:46:00-04:00,RDY,positive
1073433.0,"A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Producer Price, Wholesale Inventories Data",2019-09-11 07:35:00-04:00,RDY,neutral
1073434.0,Dr. Reddy's Laboratories Announces Launch Of Fosaprepitant For Injection In US Market,2019-09-11 07:19:00-04:00,RDY,neutral
1073435.0,"Dr. Reddy's Launches Bupropion Hydrochloride Extended-Release Tablets, USP (SR) in the U.S. Market",2019-09-05 05:28:00-04:00,RDY,neutral
1073436.0,Credit Suisse Upgrades Dr Reddy's Laboratories to Outperform,2019-09-04 11:28:00-04:00,RDY,positive
1073437.0,Dr. Reddy's Shares Spike To Session High On Uptick In Volume; Hearing Credit Suisse Upgrades From Underperform To Outperform,2019-09-04 11:21:00-04:00,RDY,positive
1073438.0,32 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-03 08:42:00-04:00,RDY,neutral
1073439.0,18 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-08-30 08:43:00-04:00,RDY,neutral
1073440.0,"Dr. Reddy's Launches Vigabatrin Powder for Oral Solution, USP in the U.S. Market",2019-08-20 03:58:00-04:00,RDY,positive
1073441.0,Dr. Reddy's Launches Versavo Biosimilar of Avastin in India,2019-08-19 04:42:00-04:00,RDY,neutral
1073442.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,RDY,negative
1073443.0,Shares of most major India-based US-listed stocks trading lower amid overall weakness in Indian markets. The iShares MSCI India ETF was down nearly 2% into the close.,2019-07-30 14:53:00-04:00,RDY,negative
1073444.0,Dr. Reddy's Q1 Sales Up 3% YoY,2019-07-29 09:17:00-04:00,RDY,neutral
1073445.0,"Dr. Reddy's Laboratories Announces Launch Of Ramelteon Tablets, In US Market",2019-07-23 06:27:00-04:00,RDY,neutral
1073446.0,Dr. Reddy's Announces Launch of OTC Store-brand Equivalent of Allegra-D 12 HR Allergy and Congestion Extended-Release Tablets in the U.S. Market,2019-07-19 03:56:00-04:00,RDY,neutral
1073447.0,Dr. Reddy's Announces the Launch of OTC Store Brand Equivalent of Mucinex D Extended Release Tablets in Two Strengths in the U.S. Market,2019-07-09 03:48:00-04:00,RDY,positive
1073448.0,"Dr. Reddy's Announces Entering into a Definitive Agreement to Sell Its Neurology Branded Products to Upsher-Smith Laboratories for $70M Upfront, $40.5M in Milestones",2019-06-14 04:12:00-04:00,RDY,positive
1073449.0,"Barclays Initiates Coverage On Dr Reddy's Laboratories with Equal-Weight Rating, Announces $39 Price Target",2019-06-11 08:59:00-04:00,RDY,neutral
1073450.0,Several India company shares are trading higher after Indian Prime Minister Narendra Modi won re-election on a 'landslide' victory.,2019-05-24 13:07:00-04:00,RDY,positive
1073451.0,Dr Reddy's Laboratories shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight.,2019-05-20 10:23:00-04:00,RDY,negative
1073452.0,Morgan Stanley Downgrades Dr. Reddy's Laboratories Ltd Common Stock to Equal-Weight,2019-05-20 07:17:00-04:00,RDY,neutral
1073453.0,"Earnings Scheduled For May 17, 2019",2019-05-17 04:12:00-04:00,RDY,neutral
1073454.0,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",2019-05-15 07:50:00-04:00,RDY,negative
1073455.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,RDY,neutral
1073456.0,Benzinga Pro's Trader Idea Feed: 'The problem now looks serious! Markets globally have a good reason to correct This will soften #CrudeOil prices which will eventually be positive for #India #Investors will get good entry point on account of escalation',2019-05-06 13:43:00-04:00,RDY,positive
1073457.0,"Dr. Reddy's Launches Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market",2019-05-06 03:54:00-04:00,RDY,neutral
1073458.0,"The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",2019-05-03 07:49:00-04:00,RDY,positive
1073459.0,Dr. Reddy's Laboratories Acquires ANDA Portfolio,2019-04-13 18:26:00-04:00,RDY,neutral
1073460.0,"The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings",2019-04-03 08:19:00-04:00,RDY,positive
1073461.0,Is India's 7.3% Growth Worth An Investment?,2019-04-02 08:15:00-04:00,RDY,positive
1073462.0,Dr. Reddy's Wholly Owned Subsidiary Promius Pharma Announces the Sale and Assignment of the US Rights for Its Marketed Dermatology Brands to Encore Dermatology,2019-04-02 05:44:00-04:00,RDY,neutral
1073463.0,"Dr. Reddy's Laboratories launches Tadalafil Tablets USP, Generic Version of Cialis, in the U.S. Market",2019-03-27 04:11:00-04:00,RDY,neutral
1073464.0,"The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering",2019-03-21 07:51:00-04:00,RDY,negative
1073465.0,"Dr. Reddy'S Laboratories Announces The Re-Launch Of Its Buprenorphine And Naloxone Sublingual Film, 2 Mg/0.5 Mg, 4 Mg/1 Mg, 8 Mg/2 Mg, And 12 Mg/3 Mg, A Therapeutic Equivalent Generic Version Of Suboxone (Buprenorphine And Naloxone) Sublingual Film, In Us",2019-02-20 12:03:00-05:00,RDY,neutral
1073466.0,31 Stocks Moving In Friday's Pre-Market Session,2019-02-15 08:20:00-05:00,RDY,neutral
1073467.0,Dr. Reddy's Launches Tadalafil Tablets USP in the U.S. Market,2019-02-12 04:21:00-05:00,RDY,neutral
1073468.0,Celgene Shares Up ~1.5% Following Report that Co Celgene Prevailed in Revlimid Patent Challenge From Dr. Reddy's,2019-02-11 13:16:00-05:00,RDY,positive
1073469.0,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",2019-02-05 07:47:00-05:00,RDY,positive
1073470.0,"Dr Reddy Laboratories Q3 EPS $0.42 Up From $0.29 YoY, Sales $553M Up From $547M YoY",2019-02-01 07:46:00-05:00,RDY,neutral
1073471.0,"Dr. Reddy's Laboratories and Its U.S. Subsidiary, Promius Pharma, Announce FDA Approval for TOSYMRA 10 mg, in the U.S. Market",2019-01-28 03:56:00-05:00,RDY,positive
1073472.0,"Dr. Reddy's Announces the Launch of Propofol Injectable Emulsion, USP in the U.S. Market",2019-01-24 04:10:00-05:00,RDY,neutral
1073473.0,Dr Reddy's Evaluating $1B+ Buyout Of Prescription Generics Business Of Perrigo,2019-01-22 03:55:00-05:00,RDY,neutral
1073474.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,RDY,neutral
1073475.0,Dr. Reddy's Launches Sevelamer Carbonate for Oral Suspension in the U.S. Market,2018-12-27 03:52:00-05:00,RDY,neutral
1073476.0,Dr. Reddy's Launches Aspirin and Extended-Release Dipyridamole Capsules in the U.S. Market,2018-12-24 04:25:00-05:00,RDY,neutral
1073477.0,"Dr. Reddy's Launches OTC Store Brand Equivalent of Prilosec OTC Tablets, 20 MG in the U.S. Market",2018-12-11 03:52:00-05:00,RDY,neutral
1073478.0,"Shares of generic drug makers are trading down on reports of expanded investigations into price fixing practices; Notable movers include Mylan down 3.5% Teva down 5.3%, Dr Reddy's Laboratories down 3.0%.",2018-12-10 10:13:00-05:00,RDY,positive
1073479.0,"Dr. Reddy's Laboratories Earlier Announced The Launch Of Chlorthalidone Tablets, USP In The U.S. Market",2018-11-28 07:47:00-05:00,RDY,neutral
1073480.0,"Dr. Reddy's  Launches Chlorthalidone Tablets, USP in the U.S. Market",2018-11-28 03:53:00-05:00,RDY,neutral
1073481.0,Aquestive Therapeutics Late Tuesday Reported That US Court Of Appeals For Federal Circuit Overturned Preliminary Injunction Against Dr. Reddy's Laboratories Relating To Suboxone Film,2018-11-21 11:44:00-05:00,RDY,neutral
1073482.0,"The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO",2018-11-21 08:04:00-05:00,RDY,negative
1073483.0,Dr. Reddy's Announces Favorable Outcome in Buprenorphine and Naloxone Sublingual Film Patent Litigation,2018-11-21 04:17:00-05:00,RDY,positive
1073484.0,"Dr. Reddy's Launches Atomoxetine Capsules, USP in the U.S. Market",2018-10-31 04:06:00-04:00,RDY,neutral
1073485.0,"Dr Reddy's Laboratories Q2 EPS $0.42 Up From $0.26 YoY, Sales $524M Down From $543M YoY",2018-10-26 09:22:00-04:00,RDY,neutral
1073486.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,RDY,positive
1073487.0,"Dr. Reddy's Laboratories Earlier Announced The Sale Of Of The Rights Of Cloderm Cream, 0.1% To EPI Health, LLC",2018-10-02 07:34:00-04:00,RDY,neutral
1073488.0,"Dr. Reddy's Announces the Sale of Its Antibiotic Manufacturing Site and Its Related Assets in Bristol, Tennessee; Terms Not Disclosed",2018-10-01 04:36:00-04:00,RDY,positive
1073489.0,Dr. Reddy's Announces That It Has Regained Worldwide Rights to DFA-02,2018-10-01 04:34:00-04:00,RDY,neutral
1073490.0,"Dr. Reddy's Launches Imatinib Mesylate Tablets, USP in the U.S. Market",2018-10-01 04:32:00-04:00,RDY,neutral
1073491.0,Dr. Reddy's Announces Launch of Hervycta (trastuzumab biosimilar) in India,2018-07-26 03:49:00-04:00,RDY,neutral
1073492.0,Dr. Reddy's Labs Confirms AstraZeneca Filed Suit Against Co. Related To Infringement Of 3 Patents On Generic Version Of Brilinta,2018-07-25 10:27:00-04:00,RDY,negative
1073493.0,"Dr. Reddy's Launches Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in U.S. Market",2018-07-20 03:51:00-04:00,RDY,neutral
1073494.0,Dr. Reddy's Labs Issues Clarification Related To New Items On Patent Infringement Case With Indivior: Sees No Direct Financial Implication Related To Compensation And/Or Penalty,2018-07-17 10:23:00-04:00,RDY,negative
1073495.0,40 Biggest Movers From Yesterday,2018-07-17 04:50:00-04:00,RDY,neutral
1073496.0,31 Stocks Moving In Monday's Mid-Day Session,2018-07-16 12:25:00-04:00,RDY,neutral
1073497.0,Dr. Reddy's Laboratories On Saturday Announced Intent To Appeal Court Decision In Preliminary Injunction Hearing For Buprenorphine And Naloxone Sublingual Film,2018-07-16 08:49:00-04:00,RDY,neutral
1073498.0,21 Stocks Moving In Monday's Pre-Market Session,2018-07-16 08:13:00-04:00,RDY,neutral
1073499.0,China Ready to Give Regulatory Approvals to Drugs Made in India as Threat of Trade War with U.S. Increases,2018-07-12 04:29:00-04:00,RDY,negative
1073500.0,"Dr. Reddy's Laboratories Announces Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market",2018-07-11 03:59:00-04:00,RDY,neutral
1073501.0,Dr. Reddy's Announces the Launch of Repatha in India,2018-07-02 07:53:00-04:00,RDY,neutral
1073502.0,"UPDATE: In Separate Decision June 15th District Court Ruled In Favor Of Eli Lilly Against Dr. Reddy's and Hospira, Preventing Them From Launching Alternative Salt Forms Of Pemetrexed Until Lilly's Patent Expires",2018-06-22 15:56:00-04:00,RDY,positive
1073503.0,Dr. Reddy's Launches Levetiracetam in Sodium Chloride Injection in the U.S. Market,2018-06-19 04:20:00-04:00,RDY,neutral
1073504.0,Dr. Reddy's In a 6-K Earlier Reports New Jersey District Court Has Issued a Temporary Restraining Order Against The Co. Regarding Further Sales and Commercializing Of Recently Approved Naloxone; Court Order Doesn't Include Prohibition On Manufacturing,2018-06-18 10:58:00-04:00,RDY,positive
1073505.0,40 Biggest Movers From Friday,2018-06-18 04:17:00-04:00,RDY,neutral
1073506.0,30 Stocks Moving In Friday's Mid-Day Session,2018-06-15 12:23:00-04:00,RDY,neutral
1073507.0,"Dr. Reddy's Issues Release Highlighting FDA Final Approval, Launch Of Buprenorphine, Naloxone Sublingual Film In US; BZ NOTE: News Has Been Previously Disclosed Elsewhere",2018-06-15 12:04:00-04:00,RDY,positive
1073508.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,RDY,neutral
1073509.0,Benzinga Pro's 6 Stocks To Watch Today,2018-06-15 08:40:00-04:00,RDY,neutral
1073510.0,25 Stocks Moving In Friday's Pre-Market Session,2018-06-15 08:16:00-04:00,RDY,neutral
1073511.0,"A Peek Into The Markets: US Stock Futures Tumble, Dow Futures Down Over 150 Points",2018-06-15 07:05:00-04:00,RDY,neutral
1073512.0,Dr. Reddy's Announces FDA Final Approval and Launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market,2018-06-15 04:50:00-04:00,RDY,positive
1073513.0,Press Release Confirms FDA Approval of Merck and Dr. Reddy's Suboxone,2018-06-14 16:49:00-04:00,RDY,positive
1073514.0,FDA Has Approved Mylan's And Dr. Reddy's Suboxone Film For Opioid Dependence,2018-06-14 16:26:00-04:00,RDY,positive
1073515.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-06-13 08:00:00-04:00,RDY,neutral
1073516.0,26 Stocks Moving In Tuesday's Pre-Market Session,2018-06-12 08:01:00-04:00,RDY,neutral
1073517.0,"Dr. Reddy's Laboratories Q4 EPS $0.28 Down From $0.29 In Same Qtr. Last Year, Sales $543M Down From $546M YoY",2018-05-22 09:15:00-04:00,RDY,neutral
1073518.0,"Earnings Scheduled For May 22, 2018",2018-05-22 04:16:00-04:00,RDY,neutral
1073519.0,"Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved",2018-05-18 08:00:00-04:00,RDY,positive
1073520.0,Dr. Reddy's Laboratories And U.S. Subsidiary Promius Pharma Earlier Announced Filing Of NDA For DFN-02  Migraine Candidate,2018-04-02 09:39:00-04:00,RDY,neutral
1073521.0,Erez Israeli Named COO of Dr. Reddy's Laboratories Replacing Abhijit Mukherjee,2018-03-29 04:03:00-04:00,RDY,neutral
1073522.0,Dr. Reddy's Launches Palonosetron Hydrochloride Injection in U.S. Market,2018-03-26 04:08:00-04:00,RDY,neutral
1073523.0,"Dr. Reddy's Laboratories Earlier Announced Launch of Levocetirizine Dihydrochloride Tablets USP, 5 mg For 24-Hours Allergy Relief In U.S. Market",2018-03-16 09:08:00-04:00,RDY,positive
1073524.0,Dr. Reddy's Laboratories Launches Tetrabenazine Tablets in the U.S. Market,2018-02-02 04:02:00-05:00,RDY,neutral
1073525.0,44 Biggest Movers From Yesterday,2018-01-26 04:43:00-05:00,RDY,neutral
1073526.0,34 Stocks Moving In Thursday's Mid-Day Session,2018-01-25 13:29:00-05:00,RDY,neutral
1073527.0,"Dr. Reddy's Reports Q3 EPS $0.32 vs $0.44 In Prior Year Period, Sales $596M vs $581M In Prior Year Period",2018-01-25 06:00:00-05:00,RDY,neutral
1073528.0,"Dr. Reddy's Reports Q3 EPS $0.32 vs $0.44 In Prior Year Period, Sales $596M vs $581M In Prior Year Period",2018-01-25 06:00:00-05:00,RDY,neutral
1073529.0,Dr. Reddy's Announces Launch of Melphalan Hydrochloride for Injection in U.S. Market,2017-12-26 06:00:00-05:00,RDY,neutral
1073530.0,Dr. Reddy's Announces $5M Settlement with Government Regarding Compliance with Consumer Product Safety Act,2017-12-19 04:01:00-05:00,RDY,positive
1073531.0,"Dr. Reddy's Announces Approval of Impoyz Cream, 0.025% First-Cycle NDA Approval",2017-12-01 04:12:00-05:00,RDY,positive
1073532.0,Dr. Reddy's Reports Launch Of Sevelamer Carbonate Tablets In US,2017-09-29 13:21:00-04:00,RDY,neutral
1073533.0,20 Stocks Moving In Thursday's Pre-Market Session,2017-09-28 08:35:00-04:00,RDY,neutral
1073534.0,12 Biggest Mid-Day Gainers For Thursday,2017-09-21 12:28:00-04:00,RDY,neutral
1073535.0,"Benzinga's Top Upgrades, Downgrades For September 21, 2017",2017-09-21 09:14:00-04:00,RDY,positive
1073536.0,Morgan Stanley Upgrades Dr. Reddy's Laboratories Ltd Common Stock to Overweight,2017-09-21 09:11:00-04:00,RDY,negative
1073537.0,18 Stocks Moving In Thursday's Pre-Market Session,2017-09-21 08:04:00-04:00,RDY,neutral
1073538.0,Mid-Afternoon Market Update: Dow Rises Over 50 Points; T2 Biosystems Shares Plummet,2017-09-15 14:31:00-04:00,RDY,positive
1073539.0,Dr. Reddy's Launches Metaxalone Tablets USP in U.S. Market,2017-09-06 04:10:00-04:00,RDY,neutral
1073540.0,18 Biggest Mid-Day Gainers For Friday,2017-09-01 12:07:00-04:00,RDY,neutral
1073541.0,20 Stocks Moving In Friday's Pre-Market Session,2017-09-01 08:02:00-04:00,RDY,neutral
1073542.0,"Dr. Reddy's Launches Cefixime for Oral Suspension, USP in the U.S. Market",2017-08-28 04:19:00-04:00,RDY,neutral
1073543.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-08-22 08:03:00-04:00,RDY,neutral
1073544.0,Dr. Reddy's Out-Licenses DFD-06 to Encore Dermatology; Promius Pharma Subsidiary to Receive Milestone Payments Up to $32.5M,2017-08-22 04:19:00-04:00,RDY,neutral
1073545.0,22 Stocks Moving In Friday's Pre-Market Session,2017-08-11 08:23:00-04:00,RDY,neutral
1073546.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-08-10 08:04:00-04:00,RDY,neutral
1073547.0,20 Biggest Mid-Day Losers For Thursday,2017-07-27 12:51:00-04:00,RDY,negative
1073548.0,"Dr. Reddy's Reports Q1 EPS $0.06 vs $0.12 Est., Sales $513M",2017-07-27 08:27:00-04:00,RDY,neutral
1073549.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-05-24 08:11:00-04:00,RDY,neutral
1073550.0,Dr. Reddy's Announces FDA Approval for Launch of Doxorubicin Hydrochloride Liposome Injection in U.S.,2017-05-17 05:04:00-04:00,RDY,positive
1073551.0,Dr Reddys Laboratories Says Reports Mentioning US FDA Started Srikakulam Inspection on March 27; No Major Observation from US FDA Yet on Srikakulam Plant are Speculative and Unverified,2017-04-03 06:09:00-04:00,RDY,negative
1073552.0,16 Stocks Moving In Tuesday's Pre-Market Session,2017-03-21 08:52:00-04:00,RDY,neutral
1073553.0,CytoSorbents Announces CytoSorb Partnership with Dr. Reddy's for S African Market,2017-03-16 07:13:00-04:00,RDY,neutral
1073554.0,"The Market In 5 Minutes: Jobs Numbers, Big Earnings Close The Week",2016-11-04 09:00:00-04:00,RDY,neutral
1073555.0,Dr. Reddy's Laboratories Reports New Strategic Deal With Gland Pharma In U.S. Market,2016-10-26 08:18:00-04:00,RDY,neutral
1073556.0,"Dr. Reddy's Q2 EPS $0.27, Revenue $539M, No Estimates",2016-10-25 06:39:00-04:00,RDY,negative
1073557.0,Dr. Reddy's Laboratories Announces the Launch of Aripiprazole & USP Tablets in US,2016-10-13 06:46:00-04:00,RDY,neutral
1073558.0,A Peek Into The Markets: U.S. Stock Futures Slide Ahead Of Consumer Price Report,2016-09-16 07:52:00-04:00,RDY,neutral
1073559.0,Dr. Reddy's Reports Expansion of Strategic Collaboration with Amgen in India,2016-09-16 06:55:00-04:00,RDY,neutral
1073560.0,Dr. Reddy's Launches Nitroglycerin Sublingual Tablets USP in the U.S. Market,2016-08-29 05:32:00-04:00,RDY,neutral
1073561.0,Credit Suisse Prescribes Underperform Rating For Dr. Reddy's With Drop In U.S. Sales,2016-07-27 14:58:00-04:00,RDY,positive
1073562.0,Premarket HSBC Downgraded Dr Reddy's Laboratories to Reduce,2016-07-27 09:36:00-04:00,RDY,neutral
1073563.0,Jefferies Downgrades Dr Reddy's Laboratories to Underperform,2016-07-27 06:44:00-04:00,RDY,neutral
1073564.0,Credit Suisse Downgrades Dr Reddy's Laboratories to Underweight,2016-07-26 16:13:00-04:00,RDY,positive
1073565.0,Benzinga's Weekend M&A Chatter,2016-06-12 22:07:00-04:00,RDY,neutral
1073566.0,Dr. Reddy's to Acquire Portfolio of Eight ANDA's from TEVA for US Market for $350M in Cash,2016-06-11 08:49:00-04:00,RDY,neutral
1073567.0,"Spectrum Pharmaceuticals Says Allos Therapeutics, Dr. Reddy's Enter into Settlement Agreement to Resolve Patent Litigation Relating to Folotyn",2016-05-31 07:04:00-04:00,RDY,positive
1073568.0,The Market In 5 Minutes: Bold Moves,2016-05-25 09:28:00-04:00,RDY,positive
1073569.0,Reddy's Labs Acquires Six OTC Brands from Ducere Pharma -Reuters,2016-05-25 05:39:00-04:00,RDY,neutral
1073570.0,Goldman Sachs Sees 8% Upside At Dr. Reddy's,2016-05-02 14:06:00-04:00,RDY,neutral
1073571.0,Benzinga's Top Initiations,2016-05-02 09:46:00-04:00,RDY,positive
1073572.0,Goldman Sachs Initiates Coverage on Dr Reddy's Laboratories at Neutral,2016-05-02 03:51:00-04:00,RDY,neutral
1073573.0,"Dr. Reddy's Acquires the Rights to Investigational Anticancer Agent E7777 for U.S., Europe, Certain Emerging Markets from Eisai",2016-03-31 05:02:00-04:00,RDY,positive
1073574.0,"Dr. Reddy's, XenoPort Announce U.S. Licensing Agreement for XP23829",2016-03-28 04:23:00-04:00,RDY,positive
1073575.0,"Dr. Reddy's, TR-Pharm Announce Strategic Collaboration in Turkey",2016-03-11 04:26:00-05:00,RDY,neutral
1073576.0,Dr.Reddy's Board Approves Up to 15.69B Rupees Buyback -Reuters,2016-02-17 04:27:00-05:00,RDY,positive
1073577.0,CLSA Upgrades Dr Reddy Laboratories to Buy,2016-02-10 07:40:00-05:00,RDY,neutral
1073578.0,"UPDATE: Dr. Reddy's US Subsidiary Promius Pharma Receives FDA Approval for Sernivo Spray, 0.05%",2016-02-08 04:08:00-05:00,RDY,positive
1073579.0,Dr. Reddy Receives FDA Approval For ZEMBRACE SymTouch Injection To Treat Acute Migraines In Adults,2016-02-02 16:39:00-05:00,RDY,positive
1073580.0,Dr. Reddy's Receives FDA Tentative Approval For Zenavod Capsules,2016-02-01 10:45:00-05:00,RDY,positive
1073581.0,"Dr. Reddy's Receives FDA Tentative Approval for Zenavod Capsules, 40 mg for Treatment of Rosacea in Adults",2016-02-01 04:15:00-05:00,RDY,positive
1073582.0,Dr. Reddy's. Receives FDA Approval for ZEMBRACE SymTouch Injection for Acute Treatment of Migraines in Adults,2016-01-29 04:11:00-05:00,RDY,positive
1073583.0,Benzinga's Top Initiations,2015-12-02 10:20:00-05:00,RDY,positive
1073584.0,Deutsche Bank Initiates Coverage on Dr Reddy Laboratories at Sell,2015-12-02 06:33:00-05:00,RDY,neutral
1073585.0,Dr. Reddy's Acknowledges Receipt of Warning Letter from FDA Regarding Manufacturing Facilities,2015-11-06 05:37:00-05:00,RDY,negative
1073586.0,Dr. Reddy's Signs Agreement to Market Bicodex Products in Romania,2015-11-04 04:16:00-05:00,RDY,positive
1073587.0,"Dr. Reddy's Reports Q2 EPS $0.64, Sales $609M, no estimates",2015-10-29 08:15:00-04:00,RDY,negative
1073588.0,Benzinga's Volume Movers,2015-09-28 10:54:00-04:00,RDY,neutral
1073589.0,"Dr. Reddy's Launches Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg",2015-09-28 04:04:00-04:00,RDY,neutral
1073590.0,US Stock Futures Signal Higher Start On Wall Street,2015-09-14 07:05:00-04:00,RDY,neutral
1073591.0,Dr. Reddy's Laboratories Signs Commercialization Deal with Hatchtech,2015-09-14 04:21:00-04:00,RDY,neutral
1073592.0,PanTheryx and Dr. Reddy's Announce an Agreement to Market PanTheryx's Proprietary Nutritional Intervention for Pediatric Infectious Diarrhea,2015-09-09 07:02:00-04:00,RDY,positive
1073593.0,The Coming Drug-Patent Cliff Is Pushing This Portfolio Up,2015-08-20 14:48:00-04:00,RDY,neutral
1073594.0,"Dr. Reddy's Q1 EPS $0.58 vs. Prior Year Quarter $0.51, Rev. $591M vs. Prior Year Quarter $553M",2015-07-30 06:51:00-04:00,RDY,neutral
1073595.0,Dr. Reddy's Files Annual Report on Form 20-F,2015-06-18 04:16:00-04:00,RDY,neutral
1073596.0,Pfizer Gets OK On Drug For Rare Lung Disorder,2015-05-29 06:52:00-04:00,RDY,positive
1073597.0,Dr. Reddy's Reports Q1 EPS $0.49,2015-05-12 07:29:00-04:00,RDY,neutral
1073598.0,"Curis to Present Data from CUDC-427, IRAK-4 Programs at AACR Annual Meeting",2015-04-14 07:06:00-04:00,RDY,neutral
1073599.0,Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield,2015-04-13 05:03:00-04:00,RDY,positive
1073600.0,Dr. Reddy's Announces Filing of Three NDAs With FDA,2015-04-08 05:20:00-04:00,RDY,neutral
1073601.0,Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories,2015-04-07 09:04:00-04:00,RDY,positive
1073602.0,Dr.Reddy's Laboratories to Acquire Select Portfolio of Established Products of UCB,2015-04-01 05:03:00-04:00,RDY,neutral
1073603.0,"Dr.Reddy's in Talks to Acquire Belgian Pharmaceutical Co UCB SA's Indian Unit for ~$135M, According to Source -Reuters",2015-03-10 05:36:00-04:00,RDY,neutral
1073604.0,Dr. Reddy's Reports Q3 EPS $0.53; Revenue $610M,2015-01-29 05:20:00-05:00,RDY,neutral
1073605.0,"Curis, Aurigene Announce Collaboration, License, Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and Precision Oncology Targets",2015-01-21 06:07:00-05:00,RDY,positive
1073606.0,Dr. Reddy's Closes Acquisition of Habitro Brand from Novartis,2014-12-19 05:00:00-05:00,RDY,neutral
1073607.0,"Dr. Reddy's Launches Valganciclovir Tablets, USP",2014-12-16 04:55:00-05:00,RDY,neutral
1073608.0,Dr. Reddy's Launches Docetaxel Injection USP,2014-11-24 04:59:00-05:00,RDY,neutral
1073609.0,Dr. Reddy's Announces The Launch Of  Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride Extended Release Tablets;,2014-11-20 09:24:00-05:00,RDY,neutral
1073610.0,Stocks Hitting 52-Week Highs,2014-11-07 10:35:00-05:00,RDY,neutral
1073611.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue,2014-10-13 05:22:00-04:00,RDY,positive
1073612.0,"Dr. Reddy's Clarifies on News Report Regarding Cadila Named in US Congress Price Probe; Says on October 2, 2014, Received Notice from Congress Committees on Price Escalation of Generic Products",2014-10-09 07:44:00-04:00,RDY,positive
1073613.0,Stocks Hitting 52-Week Highs,2014-09-25 10:17:00-04:00,RDY,neutral
1073614.0,Stocks Hitting 52-Week Highs,2014-09-24 09:58:00-04:00,RDY,neutral
1073615.0,"Dr. Reddy's Launches Levalbuterol Inhalation Solution, USP",2014-09-24 05:20:00-04:00,RDY,positive
1073616.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield,2014-08-11 05:20:00-04:00,RDY,positive
1073617.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest EPS,2014-07-31 04:40:00-04:00,RDY,positive
1073618.0,"Dr. Reddy's Laboratories Ltd Reports Q1 EPS of $0.54, Down 10% YOY; Revenue of $286.0M, Down 53% YOY",2014-07-30 08:04:00-04:00,RDY,neutral
1073619.0,Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield,2014-06-27 05:44:00-04:00,RDY,positive
1073620.0,Dr. Reddy's Launches Duloxetine Delayed-Release Capsules USP ,2014-06-27 05:24:00-04:00,RDY,neutral
1073621.0,Dr. Reddy's Launches Paricalcitol Capsules ,2014-06-25 10:23:00-04:00,RDY,neutral
1073622.0,Dr. Reddy's Names Satish Reddy as Chairman of the Board,2014-05-14 05:47:00-04:00,RDY,neutral
1073623.0,"Dr. Reddy's Laboratories Ltd Reports Q4 EPS of $0.47, Down 22% YOY; Revenue of $580.0M vs $570.50M Est",2014-05-13 07:03:00-04:00,RDY,neutral
1073624.0,"Earnings Scheduled For May 13, 2014",2014-05-13 04:32:00-04:00,RDY,neutral
1073625.0,"Dr. Reddy's Launches Fenofibrate Capsules, USP 43 mg and 130 mg ",2014-04-23 05:36:00-04:00,RDY,neutral
1073626.0,"US Stock Futures Surge Ahead Of Beige Book, Bank of America Earnings ",2014-04-16 07:07:00-04:00,RDY,neutral
1073627.0,"Dr. Reddy's Launches Eszopiclone Tablets C-IV, a Generic Version of LUNESTA, in US",2014-04-16 05:44:00-04:00,RDY,neutral
1073628.0,Dr. Reddy's Launches Amlodipine Besylate and Atorvastatin Calcium Tablets ,2014-03-27 05:37:00-04:00,RDY,neutral
1073629.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest EPS,2014-03-10 05:56:00-04:00,RDY,positive
1073630.0,Dr. Reddy's Launches Moxifloxacin Hydrochloride Tablets ,2014-03-05 05:34:00-05:00,RDY,neutral
1073631.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio ,2014-02-28 04:30:00-05:00,RDY,negative
1073632.0,"Dr. Reddy's  Launches Sumatriptan Injection USP, Autoinjector System Following FDA Approval",2014-02-26 05:42:00-05:00,RDY,positive
1073633.0,Dr Reddy's Labs Spikes to 52 Week High,2014-02-24 15:29:00-05:00,RDY,neutral
1073634.0,Dr. Reddy's Laboratories Reports Q3 EPS of $0.59 vs $0.45 Est; Revenue of $571.0M vs $558.20M Est,2014-02-11 06:00:00-05:00,RDY,neutral
1073635.0,"Earnings Scheduled For February 11, 2014",2014-02-11 04:34:00-05:00,RDY,neutral
1073636.0,Peregrine Pharmaceuticals Spikes Higher; May be Attributed to Unemon Post,2014-02-04 15:45:00-05:00,RDY,neutral
1073637.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2013-12-10 04:08:00-05:00,RDY,negative
1073638.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Profit Margin,2013-09-26 05:13:00-04:00,RDY,positive
1073639.0,US Stock Futures Edge Down Ahead Of Consumer Price Index,2013-09-17 07:13:00-04:00,RDY,neutral
1073640.0,Dr. Reddy's Announces Azacitidine for Injection Approved by FDA,2013-09-17 05:59:00-04:00,RDY,positive
1073641.0,"Dr. Reddy's Launches Donepezil Hydrochloride Tablets, 23 mg ",2013-07-28 08:58:00-04:00,RDY,neutral
1073642.0,Dr. Reddy's Launches Decitabine for Injection,2013-07-12 06:00:00-04:00,RDY,neutral
1073643.0,A Peek Into The Market Before The Trading Starts,2013-06-26 07:18:00-04:00,RDY,neutral
1073644.0,Dr. Reddy's Launches Generic Version of Lamictalets XR in US,2013-06-26 06:20:00-04:00,RDY,neutral
1073645.0,"Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Treatments- Research Report on Teva, Forest, Pharmacyclics, Cubist, and Dr. Reddy's",2013-06-19 08:02:00-04:00,RDY,neutral
1073646.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROA,2013-06-17 04:08:00-04:00,RDY,positive
1073647.0,"Fujifilm, Dr. Reddy's Terminate Plans for Joint Venture for Generic Drugs in Japan ",2013-06-03 06:01:00-04:00,RDY,neutral
1073648.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2013-05-24 04:04:00-04:00,RDY,negative
1073649.0,Dr. Reddy's Laboratories Ltd Reports Q4 EPS of $0.60 vs $0.54 Est; Revenue of $613.0M vs $561.80M Est,2013-05-14 06:47:00-04:00,RDY,neutral
1073650.0,"Dr. Reddy's Labs, Nordion Settle Claims",2013-03-22 10:40:00-04:00,RDY,neutral
1073651.0,Dr. Reddy's Holds 98.6% of OctoPlus Shares,2013-02-28 05:56:00-05:00,RDY,positive
1073652.0,"UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Dr. Reddy's Laboratories After Disappointing 3Q",2013-02-15 10:05:00-05:00,RDY,negative
1073653.0,UPDATE: Bank of America Downgrades Dr. Reddy's Laboratories to Neutral on Modest Outlook,2013-02-15 08:16:00-05:00,RDY,neutral
1073654.0,Bank of America Downgrades Dr. Reddy's Laboratories Ltd to Neutral,2013-02-15 06:32:00-05:00,RDY,neutral
1073655.0,"Earnings Scheduled For February 14, 2013",2013-02-14 00:32:00-05:00,RDY,neutral
1073656.0,Dr. Reddy's Announces Offer for OctoPlus is Unconditional ,2013-02-12 05:50:00-05:00,RDY,neutral
1073657.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield,2013-02-11 01:51:00-05:00,RDY,positive
1073658.0,A Peek Into The Market Before The Trading Starts,2013-01-25 07:18:00-05:00,RDY,neutral
1073659.0,Dr. Reddy's Launches Desloratadine ODT ,2013-01-25 05:54:00-05:00,RDY,neutral
1073660.0,A Peek Into The Market Before The Trading Starts,2013-01-03 07:19:00-05:00,RDY,neutral
1073661.0,Dr. Reddy's Launches Finasteride Tablets ,2013-01-03 06:09:00-05:00,RDY,neutral
1073662.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue,2012-12-19 03:22:00-05:00,RDY,positive
1073663.0,A Peek Into The Market Before The Trading Starts,2012-12-14 07:22:00-05:00,RDY,neutral
1073664.0,Dr. Reddy's Launches Cash Offer for OctoPlus for EUR 0.52/Share,2012-12-14 06:07:00-05:00,RDY,neutral
1073665.0,UPDATE: Credit Suisse Upgrades Dr. Reddy's Laboratories Limited to Outperform on Metropol Market Share  ,2012-12-13 13:20:00-05:00,RDY,positive
1073666.0,Credit Suisse Upgrades Dr. Reddy's Laboratories Ltd to Outperform,2012-12-12 16:08:00-05:00,RDY,positive
1073667.0,A Peek Into The Market Before The Trading Starts,2012-11-27 08:33:00-05:00,RDY,neutral
1073668.0,Dr. Reddy's Announces Saumen Chakraborty as New CFO,2012-11-27 06:41:00-05:00,RDY,neutral
1073669.0,A Peek Into The Market Before The Trading Starts,2012-11-19 07:15:00-05:00,RDY,neutral
1073670.0,Dr. Reddy's Launches Sildenafil Tablets,2012-11-19 06:24:00-05:00,RDY,neutral
1073671.0,A Peek Into The Market Before The Trading Starts,2012-10-22 07:25:00-04:00,RDY,neutral
1073672.0,Dr. Reddy's  Announces Intent to Make Offer for OctoPlus N.V. ,2012-10-22 06:09:00-04:00,RDY,neutral
1073673.0,Dr. Reddy's Announces  Launch of Montelukast Sodium Oral Granules ,2012-09-27 05:58:00-04:00,RDY,neutral
1073674.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2012-07-24 04:38:00-04:00,RDY,negative
1073675.0,Anand Rathi Upgrades Dr Reddys Laboratories from Hold to Buy,2012-06-28 08:54:00-04:00,RDY,neutral
1073676.0,"Financial Breakfast: Morning News Summary for June 6, 2012",2012-06-06 07:31:00-04:00,RDY,neutral
1073677.0,A Peek Into The Market Before The Trading Starts,2012-06-06 07:26:00-04:00,RDY,neutral
1073678.0,Dr. Reddy's Laboratories Ltd. and Merck Serono Announce Collaboration to Develop and Commercialize Biosimilars   ,2012-06-06 06:59:00-04:00,RDY,neutral
1073679.0,From Earlier: Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules  ,2012-05-21 07:51:00-04:00,RDY,neutral
1073680.0,Dr. Reddy's Revenues Cross $2 Billion Milestone* in FY12   ,2012-05-11 06:47:00-04:00,RDY,neutral
1073681.0,From Earlier: Dr. Reddy's Announces the Launch of Quetiapine Fumarate Tablets  ,2012-03-28 07:16:00-04:00,RDY,neutral
1073682.0,Seven Hot Indian Stocks,2012-02-08 06:25:00-05:00,RDY,neutral
1073683.0,Credit Suisse Downgrades Dr Reddys Laboratories from Outperform to Neutral,2012-02-07 09:54:00-05:00,RDY,positive
1073684.0,Top Performing Health Care Stocks in January,2012-02-01 06:32:00-05:00,RDY,positive
1073685.0,My three new Indian stock buys,2012-01-31 02:55:00-05:00,RDY,neutral
1073686.0,Dr. Reddy's Clarifies Media Reports   ,2012-01-27 06:52:00-05:00,RDY,positive
1073687.0,UPDATE: Teva and Dr. Reddy's Announce Launch of Generic Zyprexa® in the United States   ,2011-10-25 08:00:00-04:00,RDY,positive
1073688.0,"FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder ",2011-10-24 15:36:00-04:00,RDY,positive
1073689.0,Under The Hood: Emerging Markets Health Care,2011-10-13 13:01:00-04:00,RDY,positive
1073690.0,POZEN Provides Patent Litigation Update; Sees 2011 Revenue of $18.-19M vs   ,2011-10-04 07:35:00-04:00,RDY,negative
1073691.0,"McDonald's, MasterCard and Five Other Stocks Worth a Look Now",2011-09-29 14:33:00-04:00,RDY,positive
1073692.0,Dr. Reddy's Announces the Launch of Rivastigmine Tartrate Capsules,2011-09-22 09:08:00-04:00,RDY,neutral
1073693.0,A Peek Into The Market Before The Trading Starts,2011-09-02 07:26:00-04:00,RDY,neutral
1073694.0,"Dr. Reddy's Announces Start of Phase II Study with the CETP Inhibitor, DRL-17822 in Dyslipidemia Patients  ",2011-09-02 06:56:00-04:00,RDY,negative
1073695.0,Dr. Reddy's Announces Settlement of Lipitor ANDA Litigation with Pfizer   ,2011-08-31 11:03:00-04:00,RDY,negative
1073696.0,Dr. Reddy's Announces the Launch of Over-the-Counter Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets   ,2011-08-30 13:59:00-04:00,RDY,neutral
1073697.0,Pozen Patents Upheld in Treximet Patent Litigation   ,2011-08-08 06:32:00-04:00,RDY,negative
1073698.0,Dr. Reddy's Announces the Launch of Gemcitabine for Injection ,2011-07-27 13:27:00-04:00,RDY,neutral
1073699.0,How to Profit from Improving Relations between India and Pakistan,2011-07-27 10:02:00-04:00,RDY,positive
1073700.0,Dr. Reddy's Acquires Prescription Business of JB Chemicals & Pharmaceuticals in Russia & Other CIS Markets for $34.85M   ,2011-07-22 10:43:00-04:00,RDY,neutral
1073701.0,"Don't Miss Out On the Upcoming Boom in Biosimilars (RDY, SPPI)",2011-07-22 10:11:00-04:00,RDY,positive
1073702.0,"Don't Miss Out On the Upcoming Boom in Biosimilars (RDY, SPPI)",2011-07-22 10:11:00-04:00,RDY,positive
1073703.0,"Dr. Reddy's Chemical Manufacturing Facility at Cuernavaca, Mexico Receives Warning Letter from USFDA   ",2011-06-14 11:55:00-04:00,RDY,negative
1073704.0,*isoray Acquires Exclusive Worldwide License For Liquid Iodine,2011-06-07 07:31:00-04:00,RDY,positive
1073705.0,Top Healthcare and Major Drugs stocks to watch- Sector Performance,2011-05-22 14:55:00-04:00,RDY,positive
1073706.0,7 Stocks That Are Breaking Down,2011-05-19 15:36:00-04:00,RDY,neutral
1073707.0,Dr. Reddy's Reports EPS of $1.50; Revenues $1.68B vs. $1.68 Estimate,2011-05-13 07:05:00-04:00,RDY,neutral
1073708.0,"Indian Stocks Keep Climbing: How to Trade (WIT, TTM, HDB, RDY, EPI, SCIF, INDY, INDL, INDZ) ",2011-03-30 09:49:00-04:00,RDY,neutral
1073709.0,A Peek Into The Market Before The Trading Starts,2011-03-30 07:28:00-04:00,RDY,neutral
1073710.0,Dr. Reddy's Announces Completion of the Acquisition of US Penicillin Facility and Products from GlaxoSmithKline   ,2011-03-30 06:57:00-04:00,RDY,neutral
1073711.0,A Peek Into The Market Before The Trading Starts,2011-03-28 07:34:00-04:00,RDY,neutral
1073712.0,Dr. Reddy's Launches Levocetirizine Tablets in US   ,2011-03-28 06:52:00-04:00,RDY,neutral
1073713.0,Decent Quarter for Dr. Reddy's - Analyst Blog,2011-01-26 09:08:00-05:00,RDY,neutral
1073714.0,Decent Quarter for Dr. Reddy's - Analyst Blog,2011-01-26 08:30:00-05:00,RDY,neutral
1073715.0,5 Drug Stocks With Upside Potential of 25%,2011-01-20 10:13:00-05:00,RDY,neutral
1073716.0,Top 10 Emerging Markets Stocks in 2010,2010-12-30 11:13:00-05:00,RDY,positive
1073717.0,Macquarie Capital Markets Downgrades RDY To Neutral,2010-12-16 08:25:00-05:00,RDY,neutral
1073718.0,GlaxoSmithKline to Sell US Penicillin Facility and Productst to Dr. Reddy's Agree,2010-11-23 11:40:00-05:00,RDY,positive
1073719.0,Dr. Reddy's: Ready for Gains?  (RDY),2010-11-22 11:05:00-05:00,RDY,positive
1073720.0,9 Safe India Stocks,2010-11-19 11:26:00-05:00,RDY,positive
1073721.0,Dr. Reddy's Laboratories - Aggressive Growth,2010-10-29 02:03:00-04:00,RDY,positive
1073722.0,Respectable Quarter for Dr Reddy's - Analyst Blog,2010-10-25 11:57:00-04:00,RDY,positive
1073723.0,Zacks #5 Rank Additions for Friday  - Tale of the Tape,2010-08-27 08:36:00-04:00,RDY,neutral
1073724.0,2010 Fund Performance Period 8,2010-08-18 15:35:00-04:00,RDY,neutral
1073725.0,MakeMyTrip (MMYT) - Why Can a Barely Profitable Travel Firm IPO Rally 90% in 1 Day?  It's Indian.,2010-08-13 11:13:00-04:00,RDY,positive
1073726.0,Top India Stocks,2010-08-06 01:08:00-04:00,RDY,positive
1073727.0,"Bookkeeping: Weekly Changes to Fund Positions Year 3, Week 51",2010-07-25 23:35:00-04:00,RDY,neutral
1073728.0,Bookkeeping: Closing Dr. Reddy's Laboratories (RDY) on Technical Damage from Earnings,2010-07-22 11:41:00-04:00,RDY,negative
1073729.0,Bookkeeping: Cutting Dr. Reddy's Laboratories by 2/3rds as Chart Weakens,2010-07-21 13:39:00-04:00,RDY,negative
1073730.0,2010 Fund Performance Period 7,2010-07-20 16:14:00-04:00,RDY,neutral
1073731.0,A Look Ahead at Earnings Next Week,2010-07-16 14:23:00-04:00,RDY,neutral
1073732.0,NYT: India Expands Role as Drug Producer,2010-07-07 14:55:00-04:00,RDY,positive
1073733.0,"Bookkeeping: Weekly Changes to Fund Positions Year 3, Week 48",2010-07-06 08:17:00-04:00,RDY,neutral
1073734.0,Bookkeeping: Beginning 2 New Stakes - Dr. Reddy's Laboratories (RDY) and Polypore International (PPO),2010-07-01 11:20:00-04:00,RDY,neutral
1073735.0,Protection Purchased on Dr. Reddy’s (RDY),2010-06-09 12:26:00-04:00,RDY,neutral
1073736.0,Dr. Reddy's Laboratories (RDY) Stock Continues to Impress,2010-06-01 12:52:00-04:00,RDY,positive
1073737.0,Puts Purchased on Dr. Reddy’s (RDY),2010-05-28 15:12:00-04:00,RDY,neutral
1073738.0,Breadth Horrid,2010-05-14 14:51:00-04:00,RDY,negative
1073739.0,Dr Reddy's Swings To Profits In FQ4,2010-05-06 09:05:00-04:00,RDY,positive
1073740.0,New Era Value Investing: Chapter 3,2010-05-02 06:42:00-04:00,RDY,positive
1073741.0,Dr. Reddy's Laboratories (RDY) Impressive on Both Fundamental and Technical Basis,2009-11-09 11:56:00-05:00,RDY,positive
1073742.0,"Tim Seymour Picks Brazilian Stocks For You (ERJ, ITUB, RDY)",2009-10-23 18:33:00-04:00,RDY,neutral
1073743.0,"New 52-Week High (DRAM,ZIOP,RDY,BVF,SLH)",2009-09-25 12:43:00-04:00,RDY,neutral
